In summary, we have developed an optical platform for precise visualization of live prostate cancer cells based on vibrational spectroscopic imaging, tailored nanoprobes for plasmon enhancement and a small-molecule inhibitor of PSMA. This evidence concerns the gene FOLH1 and prostate carcinoma.